BPC-157 treatment in fibroblast cell models demonstrates dose-dependent increases in paxillin phosphorylation at Y31 and Y118 residues, measured using quantitative immunofluorescence and flow cytometry-based approaches
Pharmaceutical-grade purity Triple-action formula for healing, recovery, and skin health Backed by science for improved wellness and performance Suggested Use: For research purposes only
Subsequent studies demonstrated that exogenous administration of thymosin beta-4 promoted corneal wound healing, dermal repair, and cardiac tissue recovery in rodent models
Research Application and Potential Benefits of BPC-157 BPC-157 has been studied for its potential benefits in various tissue and healing models
You can view sample reports on our Lab Reports page
In participants with type 2 diabetes, HbA1c improved by 2.2%, with 82% of participants reaching HbA1c levels at or below 6.5%